KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, will be presenting at the 3rd Annual “Cancer Immunotherapy: A Long-Awaited Reality Conference” on October 4, 2012 at 11:30 a.m. EDT at the New York Academy of Medicine in New York City.
